 Home > Active Ingredient News > Drugs Articles > Heavyweight｜Jingtai Technology and Qingyu Medicine jointly launch a number of AI anti-tumor pipeline research and development

Heavyweight｜Jingtai Technology and Qingyu Medicine jointly launch a number of AI anti-tumor pipeline research and development

 Last Update: 2021-03-30
 Source: Internet
 Author: User

Tags

computational chemistry jobs

what drug allopurinol used

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

544px;text-align:center;white-space:normal;background-color:#FFFFFF;overflow-wrap:break-word ;'>us" style="margin:0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;transform:rotate(0deg);">33);border-width:0px;">us" style="margin:0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">79);vertical-align:top;flex:100 100 0%;align-self:flex-start;height:auto;">us" style="margin:10px 0px 20px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">8;letter-spacing:1px;">

In March 2021, Jingtai Technology, an artificial intelligence drug research and development company driven by digitization and intelligence, announced that it has reached a strategic cooperation with Qingyu Pharmaceutical, a company focused on first-in-class drug research and development, to provide multiple anti-tumor drugs Target launches drug research and development cooperation.
As the world's leading artificial intelligence (AI) drug research and development company, Jingtai Technology will take AI, high-precision computational chemistry and other advanced technologies as the core, combining expert experience and drug experimental research capabilities to provide Qingyu Medicine with an "integrated" Drug discovery services reduce the cost and cycle of drug development and increase the success rate.

us" style="margin:0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;transform:rotate(0deg);">33);border-width:0px;">us" style="margin:0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">79);vertical-align:top;flex:100 100 0%;align-self:flex-start;height:auto;">us" style="margin:10px 0px 20px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">8;letter-spacing:1px;">

33);border-width:0px;">us" style="margin:0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">79);vertical-align:top;flex:100 100 0%;align-self:flex-start;height:auto;">us" style="margin:10px 0px 20px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">8;letter-spacing:1px;">

us" style="margin:0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">79);vertical-align:top;flex:100 100 0%;align-self:flex-start;height:auto;">us" style="margin:10px 0px 20px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">8;letter-spacing:1px;">

79);vertical-align:top;flex:100 100 0%;align-self:flex-start;height:auto;">us" style="margin:10px 0px 20px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">8;letter-spacing:1px;">

us" style="margin:10px 0px 20px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">8;letter-spacing:1px;">

8;letter-spacing:1px;">

As the world's leading artificial intelligence (AI) drug research and development company, Jingtai Technology will take AI, high-precision computational chemistry and other advanced technologies as the core, combining expert experience and drug experimental research capabilities to provide Qingyu Medicine with an "integrated" Drug discovery services reduce the cost and cycle of drug development and increase the success rate.
544px;white-space:normal;background-color:#FFFFFF;text-align:justify;overflow-wrap:break-word ;'>544px;text-align:center;white-space:normal;background-color:#FFFFFF;overflow-wrap:break-word ;'>us" style="margin:0px;padding:0px 5px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">75em;">Facing the increasingly serious problem of population aging and the increasing incidence of tumors, the pharmaceutical industry is facing severe social challenges, and many diseases still lack effective treatment drugs.

Jingtai Technology and Qingyu Pharmaceutical hope to achieve a strong combination of AI technology and the experience of drug R&D experts through cooperation.
Through AI molecular generation, virtual screening, high-precision activity prediction, high-throughput experimental verification and other means, a novel framework and structure can be obtained.

At the same time, Jingtai Technology adheres to the concept of "from the end to the beginning" and has built a high-level drug research and development and drug experiment team, combining AI with expert experience and experimental research to provide customers and partners with a "one-stop shop" Drug discovery service.

75em;">

75em;"> Qingyu Pharmaceutical focuses on the research and development of small molecule innovative drugs targeting the WD40 protein family.

Based on structural biology, the company combines high-throughput screening, disease biology and medicinal chemistry and other functions to deepen and lead the WD40 protein family related fields, discover new pathogenic mechanisms, verify new targets, and develop first-in-class Small molecule drugs to solve unmet medical needs and benefit patients.

us" style="margin:0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;transform:rotate(0deg);">

75em;">

8;">75em;">

us" style="margin:0px;padding:0px 5px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">75em;">Facing the increasingly serious problem of population aging and the increasing incidence of tumors, the pharmaceutical industry is facing severe social challenges, and many diseases still lack effective treatment drugs.

75em;">

75em;"> Qingyu Pharmaceutical focuses on the research and development of small molecule innovative drugs targeting the WD40 protein family.

us" style="margin:0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;transform:rotate(0deg);">

75em;">

75em;">Facing the increasingly serious problem of population aging and the increasing incidence of tumors, the pharmaceutical industry is facing severe social challenges, and many diseases still lack effective treatment drugs.

Jingtai Technology and Qingyu Pharmaceutical hope to achieve a strong combination of AI technology and the experience of drug R&D experts through cooperation.

75em;"> XtalPi takes artificial intelligence, quantum physics, quantum chemistry and cloud computing as the core, and has built the world's leading artificial intelligence drug discovery platform-Intelligent Digital Drug Discovery and Development (ID4 platform), which can quickly generate millions Grade new molecular structure, and through AI molecular screening model and high-precision binding free energy prediction method, the produced molecules are evaluated for druggability, activity, ADME/T properties, and target binding energy.
At the same time, Jingtai Technology adheres to the concept of "from the end to the beginning" and has built a high-level drug research and development and drug experiment team, combining AI with expert experience and experimental research to provide customers and partners with a "one-stop shop" Drug discovery service.

XtalPi takes artificial intelligence, quantum physics, quantum chemistry and cloud computing as the core, and has built the world's leading artificial intelligence drug discovery platform-Intelligent Digital Drug Discovery and Development (ID4 platform), which can quickly generate millions Grade new molecular structure, and through AI molecular screening model and high-precision binding free energy prediction method, the produced molecules are evaluated for druggability, activity, ADME/T properties, and target binding energy.
XtalPi takes artificial intelligence, quantum physics, quantum chemistry and cloud computing as the core, and has built the world's leading artificial intelligence drug discovery platform-Intelligent Digital Drug Discovery and Development (ID4 platform), which can quickly generate millions Grade new molecular structure, and through AI molecular screening model and high-precision binding free energy prediction method, the produced molecules are evaluated for druggability, activity, ADME/T properties, and target binding energy.
At the same time, Jingtai Technology adheres to the concept of "from the end to the beginning" and has built a high-level drug research and development and drug experiment team, combining AI with expert experience and experimental research to provide customers and partners with a "one-stop shop" Drug discovery service.

75em;">

75em;"> Qingyu Pharmaceutical focuses on the research and development of small molecule innovative drugs targeting the WD40 protein family.
Based on structural biology, the company combines high-throughput screening, disease biology and medicinal chemistry and other functions to deepen and lead the WD40 protein family related fields, discover new pathogenic mechanisms, verify new targets, and develop first-in-class Small molecule drugs to solve unmet medical needs and benefit patients.

Qingyu Pharmaceutical focuses on the research and development of small molecule innovative drugs targeting the WD40 protein family.
Qingyu Pharmaceutical focuses on the research and development of small molecule innovative drugs targeting the WD40 protein family.
Based on structural biology, the company combines high-throughput screening, disease biology and medicinal chemistry and other functions to deepen and lead the WD40 protein family related fields, discover new pathogenic mechanisms, verify new targets, and develop first-in-class Small molecule drugs to solve unmet medical needs and benefit patients.
us" style="margin:0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;transform:rotate(0deg);">

us" style="margin:0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;transform:rotate(0deg);">

75em;">

75em;overflow-wrap:break-word ;">us" style="margin:5px 0px 0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">us" style="margin:0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">us" style="margin:5px 0px 0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">us" style="margin:0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">us" style="margin:5px 0px 0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">us" style="margin:0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">us" style="margin:0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">us" style="margin:0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">us" style="margin:0px;padding:0px 5px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;line-height:1.
8;">75em;">
75em;">Dr.
Ma Jian, Co-founder and CEO of Jingtai Technology, said: “It is the responsibility of medical practitioners to improve R&D efficiency and create more high-quality and low-cost anti-tumor drugs.
Qingyu Pharmaceutical’s anti-tumor drug research and development project is used.
I believe that the one-stop drug discovery model created by Jingtai Technology that integrates expert experience, artificial intelligence algorithms and high-throughput experimental capabilities has advantages compared with classic drug research and development methods.
Unique advantages can better help the early development of anti-tumor drugs.
"75em;">
75em;">75em;">Dr.
Ma Jian, Co-founder and CEO of Jingtai Technology, said: “It is the responsibility of medical practitioners to improve R&D efficiency and create more high-quality and low-cost anti-tumor drugs.
Qingyu Pharmaceutical’s anti-tumor drug research and development project is used.
I believe that the one-stop drug discovery model created by Jingtai Technology that integrates expert experience, artificial intelligence algorithms and high-throughput experimental capabilities has advantages compared with classic drug research and development methods.
Unique advantages can better help the early development of anti-tumor drugs.
"，CEO ：“，、， AI ，、，，。”“，、， AI ，、，，。”75em;">75em;overflow-wrap:break-word ;">us" style="margin:5px 0px 0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">us" style="margin:0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">us" style="margin:5px 0px 0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">us" style="margin:0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">us" style="margin:5px 0px 0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">us" style="margin:0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">us" style="margin:0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">us" style="margin:0px;padding:0px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;">us" style="margin:0px;padding:0px 5px;max-width:100%;box-sizing:border-box;overflow-wrap:break-word ;line-height:1.
8;">75em;">

75em;"> ，：“， first-in-class ，，，。AI ，，。，CADD，，，。”

75em;">

75em;"> ，：“， first-in-class ，，，。AI ，，。，CADD，，，。”

，：“， first-in-class ，，，。AI ，，。，CADD，，，。”“， first-in-class ，，，。AI ，，。，CADD，，，。”

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.